Journal Title：Endocrine

Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.

Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.

Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.

Endocrine 是當(dāng)今快速發(fā)展的實(shí)驗(yàn)和臨床研究領(lǐng)域的主要期刊，發(fā)表致力于內(nèi)分泌和代謝各個(gè)領(lǐng)域的基礎(chǔ)（包括分子、細(xì)胞和生理研究）、轉(zhuǎn)化和臨床研究的原創(chuàng)文章。文章的接受將基于同行評(píng)審、優(yōu)先級(jí)和編輯決定。期刊將發(fā)表受邀評(píng)論、小型評(píng)論和相關(guān)病理生理和臨床主題的觀點(diǎn)，以及期刊文章的社論。編輯團(tuán)隊(duì)將評(píng)估未經(jīng)請(qǐng)求的社論?？梢蕴峤豢茖W(xué)會(huì)議的成果以及指南和立場(chǎng)聲明。期刊還考慮內(nèi)分泌遺傳學(xué)和表觀遺傳學(xué)領(lǐng)域的專(zhuān)題文章，以及致力于內(nèi)分泌學(xué)新方法和技術(shù)的文章。

Endocrine 涵蓋有爭(zhēng)議的臨床內(nèi)分泌問(wèn)題。還接受內(nèi)分泌和代謝主題的薈萃分析。除非有特別的興趣，否則不會(huì)發(fā)表單個(gè)臨床病例和/或小患者研究的描述。但是，可以考慮單個(gè)患者的新型成像研究和內(nèi)分泌副作用報(bào)告。可以提交與最近發(fā)表的文章相關(guān)或不相關(guān)的研究信和致編輯的信。

內(nèi)分泌涵蓋內(nèi)分泌學(xué)的主要主題，例如神經(jīng)內(nèi)分泌學(xué)、垂體和下丘腦肽、甲狀腺生理和臨床方面、骨骼和礦物質(zhì)代謝和骨質(zhì)疏松癥、肥胖、脂質(zhì)和能量代謝和食物攝入控制、胰島素、1 型和 2 型糖尿病、男性和女性生殖激素、腎上腺疾病兒科和老年內(nèi)分泌學(xué)、內(nèi)分泌性高血壓和內(nèi)分泌腫瘤學(xué)。

Endocrine創(chuàng)刊于1995年，由Springer US出版商出版，收稿方向涵蓋ENDOCRINOLOGY & METABOLISM全領(lǐng)域，此刊是中等級(jí)別的SCI期刊，所以過(guò)審相對(duì)來(lái)講不是特別難，但是該刊專(zhuān)業(yè)認(rèn)可度不錯(cuò)，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約1.5月 ，影響因子指數(shù)3，該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。